Date published: 2026-2-2

1-800-457-3801

SCBT Portrait Logo
Seach Input

SC 58125 (CAS 162054-19-5)

0.0(0)
Write a reviewAsk a question

Alternate Names:
5-(4-fluorophenyl)-1-(4-methylsulfonylphenyl)-3-(trifluoromethyl)pyrazole
Application:
SC 58125 is a selective Cox-2 inhibitor
CAS Number:
162054-19-5
Molecular Weight:
384.35
Molecular Formula:
C17H12F4N2O2S
Supplemental Information:
This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

SC 58125 is a selective, time-dependent, and irreversible cyclooxygenase-2 (Cox-2) inhibitor that displays anti-inflammatory properties. In addition to inhibiting Cox-2 (IC50 of 0.04 μM), SC 58125 is found to reversibly inhibit Cox-1 (IC50 of >100 μM), which is expressed in most tissues and organs. Experiments suggest that SC 58125 is also capable of suppressing cell proliferation by causing a progression delay at the G2/M transition.


SC 58125 (CAS 162054-19-5) References

  1. Aspirin, but not the more selective cyclooxygenase (COX)-2 inhibitors meloxicam and SC 58125, aggravates postischaemic cardiac dysfunction, independent of COX function.  |  Heindl, B. and Becker, BF. 2001. Naunyn Schmiedebergs Arch Pharmacol. 363: 233-40. PMID: 11218076
  2. A cyclooxygenase-2 inhibitor (SC-58125) blocks growth of established human colon cancer xenografts.  |  Williams, CS., et al. 2001. Neoplasia. 3: 428-36. PMID: 11687954
  3. The Role of Cyclooxygenase-2 in Inflammation.  |  Masferrer, JL., et al. 1995. Am J Ther. 2: 607-610. PMID: 11854834
  4. Gene modulation by Cox-1 and Cox-2 specific inhibitors in human colorectal carcinoma cancer cells.  |  Bottone, FG., et al. 2004. Carcinogenesis. 25: 349-57. PMID: 14633654
  5. Participation of cyclooxygenase-1 in prostaglandin E2 release from synovitis tissue in primary osteoarthritis in vitro.  |  Knorth, H., et al. 2004. Osteoarthritis Cartilage. 12: 658-66. PMID: 15262246
  6. Inhibitory effects of Celecoxib and Sc-58125 on proliferation of human carcinoma of larynx Hep-2 in vitro.  |  Ding, J., et al. 2005. J Huazhong Univ Sci Technolog Med Sci. 25: 202-5. PMID: 16116973
  7. Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2.  |  Atar, S., et al. 2006. Am J Physiol Heart Circ Physiol. 290: H1960-8. PMID: 16339820
  8. Cyclooxygenase-2 independent effects of cyclooxygenase-2 inhibitors on oxidative stress and intracellular glutathione content in normal and malignant human B-cells.  |  Ryan, EP., et al. 2008. Cancer Immunol Immunother. 57: 347-58. PMID: 17668203
  9. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain.  |  Seibert, K., et al. 1994. Proc Natl Acad Sci U S A. 91: 12013-7. PMID: 7991575
  10. A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors.  |  Gierse, JK., et al. 1996. J Biol Chem. 271: 15810-4. PMID: 8663121

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

SC 58125, 10 mg

sc-204267
10 mg
$113.00

SC 58125, 50 mg

sc-204267A
50 mg
$550.00